SINOVAC BIOTECH LTD's ticker is SVA and the CUSIP is P8696W104. A total of 50 filers reported holding SINOVAC BIOTECH LTD in Q2 2014. The put-call ratio across all filers is 4.86 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $113,000 | +94.8% | 17,731 | +75.9% | 0.00% | +200.0% |
| Q4 2015 | $58,000 | -37.6% | 10,080 | -43.1% | 0.00% | -50.0% |
| Q2 2015 | $93,000 | +43.1% | 17,720 | +31.0% | 0.00% | +100.0% |
| Q3 2014 | $65,000 | -43.5% | 13,526 | -33.5% | 0.00% | -50.0% |
| Q2 2014 | $115,000 | -66.5% | 20,347 | -57.3% | 0.00% | -50.0% |
| Q1 2014 | $343,000 | +114.4% | 47,676 | +77.7% | 0.00% | +100.0% |
| Q3 2013 | $160,000 | – | 26,837 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Verity Asset Management, Inc. | 35,884 | $188,000 | 0.17% |
| Orbimed Advisors | 2,667,500 | $14,004,000 | 0.10% |
| Freedom Investment Management, Inc. | 157,295 | $826,000 | 0.08% |
| Pine River Capital Management L.P. | 1,095,041 | $5,749,000 | 0.06% |
| FIRST MANHATTAN CO. LLC. | 603,666 | $3,169,000 | 0.02% |
| FIL Ltd | 1,091,500 | $5,730,000 | 0.02% |
| Renaissance Technologies | 1,263,200 | $6,632,000 | 0.02% |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 179,899 | $944,000 | 0.01% |
| WELLINGTON MANAGEMENT GROUP LLP | 4,068,406 | $21,359,000 | 0.01% |
| ProShare Advisors LLC | 44,592 | $234,000 | 0.00% |